Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
2
×
national top stories
new york blog main
new york top stories
abbvie
acorda therapeutics
alder biopharmaceuticals
amgen
ampyra
apokyn
apomorphine
biotech
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
dalfampridine
david rind
detroit blog main
detroit top stories
duopa
eli lilly
episodic migraine
eptinezumab
erenumab
fda
food and drug administration
fremanezumab
galcanezumab
inbrija
indiana blog main
indiana top stories
institute for clinical and economic review
migraine research foundation
migraines
mylan
What
drug
fda
gets
2
×
new
2
×
nod
2
×
acorda
amgen
approval
approved
candidates
class
cope
developed
disease
episodes
friday
head
help
late
looms
meant
medications
medicines
migraine
pain
parkinson’s
patients
preventive
rival
starts
stop
treatment
won
working
Language
Current search:
gets
×
new
×
" national blog main "
×
nod
×
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines